Monitoring of patients taking canthaxanthin and carotene: an electroretinographic and ophthalmological survey

Hum Toxicol. 1989 Nov;8(6):439-50. doi: 10.1177/096032718900800603.

Abstract

1. Patients who have taken canthaxanthin and beta-carotene to avert phototoxicity have been monitored by electroretinographic testing. 2. Patients took the compounds only during the summer months, but were monitored for more than 1 year to determine if seasonal changes in the ERG were visible. 3. The characteristic refractile retinal crystals reduced during the winter. 4. The scotopic b-wave amplitude increased during the winter, whether evoked by red or blue flashes. 5. No other ERG parameter altered. 6. Changes noted in 3 and 4 above are reversible. 7. A dose/ERG-amplitude response relationship was established, but no correlation between blood level or total cumulative dose and b-wave amplitude could be found. 8. It is suggested that the Müller cells concentrate canthaxanthin and this is the mechanism which affects the ERG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Canthaxanthin
  • Carotenoids / administration & dosage
  • Carotenoids / analogs & derivatives*
  • Carotenoids / blood
  • Carotenoids / pharmacology*
  • Electroretinography*
  • Female
  • Humans
  • Monitoring, Physiologic
  • Ophthalmic Solutions
  • Retina / drug effects

Substances

  • Ophthalmic Solutions
  • Carotenoids
  • Canthaxanthin